APOB and hepatocellular carcinoma: Similarly, HCC patients with high expression of CD34/APOB/PTPRC/SELE/IL10 were remarkably correlated with better PFS (Fig. 10B,F,J; Supplementary Fig. S1B,F) and RFS (Fig. 10C,G,K; Supplementary Fig. S1C,G).